Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 14, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

Jan. 9, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Comprehensive Update of Biosimilar Therapies: Your Questions Answered

Dec. 11, 2017

Gain a better understanding of the evidence currently available on biosimilars for IBD and how to educate/discuss biosimilars with patients.

Help! My IBD Patient Is Failing Conventional Therapy

Nov. 15, 2017

The answer to this common challenge involves a better understanding of the currently available treatments.

Preparation Crucial for Adolescents Transferring to Adult IBD Care

Nov. 9, 2017

Psychological readiness, logistical barriers and appropriate selection of adult care providers are key.

Meta-Analysis Findings May Incentivize Mothers with IBD to Breastfeed Longer

Nov. 9, 2017

Reduced risk of IBD, especially with breastfeeding exposure of at least 12 months

Grant Spotlight: AGA Pilot Awards

Nov. 8, 2017

Take your new research project idea and make it a reality with an AGA research award. Eight grants are open with a Jan. 12, 2018, deadline.

For IBD Patients, Transitions Are a Challenge

Nov. 1, 2017

IBD experts provide tips to help your patients as they transition from pediatric to adult care, or to a new physician when going off to college.

The Lowdown on the Low-FODMAP Diet

Nov. 1, 2017

As the low-FODMAP diet grows in popularity, know the facts to help answer patient questions and provide guidance.

Concurrent IBD Present in Most Primary Sclerosing Cholangitis

Oct. 26, 2017

Unique phenotype for differentiating primary from IgG4 sclerosing cholangitis, but underlying joint mechanisms unclear.

Can You Explain Biosimilars to Patients?

Oct. 25, 2017

AGA is taking the lead in educating health care professionals and their patients about biosimilars and how they can play a role in IBD patient care.

How to Select the Best FMT Donor

Oct. 25, 2017

Dr. Gail Hecht debunks the myth that a patient’s family or friend is the best donor for a fecal microbiota transplantation.

Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn’s Disease: A Systematic Review of Randomized Trials

Oct. 22, 2017

We performed a systematic review of randomized trials comparing chromoendoscopy vs other endoscopic techniques for dysplasia surveillance in inflammatory bowel diseases.

Agreement Between Home-Based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity

Oct. 22, 2017

For patients with concentrations of fecal calprotectin above this level, findings from IBDoc should be confirmed by another method.

Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months

Oct. 22, 2017

We investigated whether serum trough levels of vedolizumab, during the induction phase can determine whether patients need additional doses within 6 months.

How Will Translational Advances in Pediatric IBD Affect Practices?

Oct. 17, 2017

Dr. Rosen will discuss how new findings can make a difference for pediatric IBD patients at the Crohn’s & Colitis Congress.

Stepped-Up Moves to Understand, Diagnose IBD-Related Autoimmune Pancreatitis

Oct. 12, 2017

Possible genetic overlap; concurrence shown to affect clinical course, pancreatic cancer risk.

Apply Biomarkers to Better Target Therapies to IBD Patients

Oct. 12, 2017

Dr. Lee A. Denson will present his findings on biomarkers in Las Vegas at the Crohn’s & Colitis Congress.

One-Day Behavioral Intervention for Patients With Inflammatory Bowel Disease and Co-Occurring Psychological Distress

Oct. 11, 2017

We aimed to determine the feasibility of a 1-day ACT-ED workshop in patients with IBD.

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.

GIs Should be Able to Prescribe the Most Beneficial Treatments

Oct. 4, 2017

AGA supports Restoring the Patient’s Voice Act — new legislation that facilitates treatment appeals to insurance companies.

Blog: 3-D Imaging of T-Cell Localization in Inflamed Colon Tissues

Oct. 3, 2017

Researchers report that light sheet fluorescence microscopy (LSFM) can better assess IBD progression and the effects of therapeutic agents. Read more in the AGA Journals blog.

Biologic Therapy, Risk Estimation Dominate Pediatric IBD Research

Sept. 28, 2017

New findings show inflammatory bowel disease (IBD) is on the rise in children in North America.